BLFS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BLFS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-06), BioLife Solutions's current share price is $21.54. BioLife Solutions's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $4.58. BioLife Solutions's Cyclically Adjusted PB Ratio for today is 4.70.
The historical rank and industry rank for BioLife Solutions's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, BioLife Solutions's highest Cyclically Adjusted PB Ratio was 242.89. The lowest was 2.28. And the median was 7.68.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
BioLife Solutions's adjusted book value per share data for the three months ended in Mar. 2024 was $7.297. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $4.58 for the trailing ten years ended in Mar. 2024.
The historical data trend for BioLife Solutions's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLife Solutions Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 6.27 | 5.83 | 3.37 | 3.73 | 4.05 |
For the Medical Instruments & Supplies subindustry, BioLife Solutions's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, BioLife Solutions's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where BioLife Solutions's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
BioLife Solutions's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 21.54 | / | 4.58 | |
= | 4.70 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioLife Solutions's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, BioLife Solutions's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 7.297 | / | 131.7762 | * | 131.7762 | |
= | 7.297 |
Current CPI (Mar. 2024) = 131.7762.
BioLife Solutions Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201406 | 1.114 | 100.560 | 1.460 |
201409 | 1.051 | 100.428 | 1.379 |
201412 | 0.977 | 99.070 | 1.300 |
201503 | 0.895 | 99.621 | 1.184 |
201506 | 0.825 | 100.684 | 1.080 |
201509 | 0.752 | 100.392 | 0.987 |
201512 | 0.683 | 99.792 | 0.902 |
201603 | 0.595 | 100.470 | 0.780 |
201606 | 0.541 | 101.688 | 0.701 |
201609 | 0.483 | 101.861 | 0.625 |
201612 | 0.246 | 101.863 | 0.318 |
201703 | 0.215 | 102.862 | 0.275 |
201706 | 0.516 | 103.349 | 0.658 |
201709 | 0.541 | 104.136 | 0.685 |
201712 | 0.720 | 104.011 | 0.912 |
201803 | 0.740 | 105.290 | 0.926 |
201806 | 1.220 | 106.317 | 1.512 |
201809 | 2.409 | 106.507 | 2.981 |
201812 | 0.789 | 105.998 | 0.981 |
201903 | 2.370 | 107.251 | 2.912 |
201906 | 2.448 | 108.070 | 2.985 |
201909 | 3.783 | 108.329 | 4.602 |
201912 | 2.087 | 108.420 | 2.537 |
202003 | 3.202 | 108.902 | 3.875 |
202006 | 4.074 | 108.767 | 4.936 |
202009 | 5.815 | 109.815 | 6.978 |
202012 | 6.212 | 109.897 | 7.449 |
202103 | 6.207 | 111.754 | 7.319 |
202106 | 11.151 | 114.631 | 12.819 |
202109 | 11.805 | 115.734 | 13.441 |
202112 | 11.432 | 117.630 | 12.807 |
202203 | 11.304 | 121.301 | 12.280 |
202206 | 9.693 | 125.017 | 10.217 |
202209 | 9.560 | 125.227 | 10.060 |
202212 | 8.503 | 125.222 | 8.948 |
202303 | 8.272 | 127.348 | 8.560 |
202306 | 8.106 | 128.729 | 8.298 |
202309 | 7.575 | 129.860 | 7.687 |
202312 | 7.476 | 129.419 | 7.612 |
202403 | 7.297 | 131.776 | 7.297 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of BioLife Solutions's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Geraint Phillips | officer: SVP, Global Operations | 3303 MONTE VILLA, #310, BOTHELL WA 98021 |
Sarah Aebersold | officer: VP, Global Human Resources | BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, BOTHELL WA 98021 |
Troy Wichterman | officer: Chief Financial Officer | 3303 MONTE VILLA PARKWAY, BOTHELL WA 98021 |
Greef Roderick De | director | |
Aby J. Mathew | officer: Chief Tech. Officer & Sr. VP | 3303 MONTE VILLA PARKWAY, #310, BOTHELL WA 98021 |
Todd Berard | officer: Vice President, Marketing | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Karen A. Foster | officer: Vice President of Operations | C/O BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Michael Rice | director, officer: President & CEO | C/O BIOLIFE SOLUTIONS, INC., 171 FRONT STREET, OWEGO NY 13827 |
Casdin Partners Master Fund, L.p. | 10 percent owner | WALKER HOUSE, 87 MARY STREET, GEORGE TOWN E9 KY1-9001 |
Garrie Richardson | officer: Chief Revenue Officer | 3303 MONTE VILA PARKWAY, BOTHELL WA 98021 |
Marcus Schulz | officer: Vice President, Global Sales | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL WA 98021 |
Joseph C Schick | director | 16719 NE 139TH PLACE, WOODINVILLE WA 98072 |
Amy Duross | director | 8410 GOLDEN BEAR PLACE, WHISTLER A1 V8E 1J7 |
Timothy L. Moore | director | C/O KITE PHARMA, INC., 2225 COLORADO AVE., SANTA MONICA CA 90404 |
Joydeep Goswami | director | SUMITOMO FUDOSAN MITA TWIN BLDG, EAST WING 4-2-8 SHIBAURA MINATO-KU, TOKYO M0 1080023 |
From GuruFocus
By PRNewswire • 08-08-2023
By PRNewswire PRNewswire • 07-09-2022
By GuruFocus Research • 05-27-2023
By PRNewswire PRNewswire • 06-14-2023
By PRNewswire PRNewswire • 06-29-2022
By PRNewswire PRNewswire • 01-09-2023
By GuruFocus Research GuruFocus Editor • 01-06-2023
By PRNewswire PRNewswire • 06-09-2022
By PRNewswire PRNewswire • 01-17-2023
By PRNewswire • 07-27-2023